-

Exactech Announces New Patent, Strengthening Company’s Position in Joint Replacement Soft Tissue Management

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent #11,278,338 for the Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way.

“The patent allowance supports the uniqueness of Newton and its ability to maintain a force-controlled environment regardless of the joint gap through antagonist sub-mechanisms,” said Laurent Angibaud, Vice President of Advanced Surgical Technologies at Exactech. “While initially dedicated to total knee arthroplasty, Newton has the potential to be applied to other joints where proper soft tissue management is of paramount importance.”

The patent recognizes Newton’s sophisticated approach to providing critical soft tissue data that helps orthopaedic surgeons execute a total knee replacement with precision. Newton is unique in that it captures active balance data through the entire arc of motion with the patella in place and seamlessly integrates with ExactechGPS® to allow surgeons the ability to visualize a predictive plan through quantifiable insights. This results in a powerful system that is designed for a dynamic, patient-specific and reproducible outcome.

“This recognition is a significant achievement for Exactech,” said Darin Johnson, Exactech President and CEO. “The patent not only protects the commercial potential of the Newton Knee, but it also demonstrates our unwavering commitment to protecting innovation around our entire Active Intelligence® suite of technologies.”

The Newton Knee is in pilot release with limited launch planned for later this year. For more information on Newton and the Active Intelligence portfolio, visit www.AIExactech.com.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and Twitter.

Contacts

Courtney Adkins,
Marketing Communications Sr. Manager
media@exac.com

Exactech

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI

Release Versions

Contacts

Courtney Adkins,
Marketing Communications Sr. Manager
media@exac.com

More News From Exactech

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe. “We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innov...
Back to Newsroom